3(top 5%)
Impact Factor
3.5(top 5%)
extended IF
69(top 5%)
H-Index
899
authors
2,322
papers
41,181
citations
4,476
citing journals
25,986
citing authors

Most Cited Articles of Digestive Diseases in 2010

TitleYearCitations
Epidemiology of non-alcoholic fatty liver disease2010612
Bile acids as regulators of hepatic lipid and glucose metabolism2010211
The role of cytokines in non-alcoholic fatty liver disease2010166
Epidemiology of pancreatic cancer: an update2010151
Gut-liver axis and sensing microbes2010129
The natural history of non-alcoholic fatty liver disease2010125
Animal models of non-alcoholic steatohepatitis: of mice and man2010110
Gastric cancer: epidemiology and risk factors2010103
The role of chemokines in the recruitment of lymphocytes to the liver201095
Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease201090
Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity201083
Liver fat in the pathogenesis of insulin resistance and type 2 diabetes201082
Pancreatic cancer: epidemiology and risk factors201073
Inflammatory bowel disease as a risk factor for colorectal cancer201063
Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD201062
Genetic and environmental susceptibility to non-alcoholic fatty liver disease201061
Occult hepatitis B virus infection: detection and significance201060
Alcohol abuse, endoplasmic reticulum stress and pancreatitis201057
Systemic symptoms in non-alcoholic fatty liver disease201049
Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?201049
Hepatotoxicity of agents used in the management of inflammatory bowel disease201048
The role of non-alcoholic fatty liver disease in cardiovascular disease201048
New serologic markers for inflammatory bowel disease diagnosis201047
The effect of lifestyle changes in non-alcoholic fatty liver disease201045
Chemokines in inflammatory bowel diseases201044